Glycogen Synthase Kinase 3ß Inhibitor (2'Z,3'E)-6-Bromo-indirubin- 3'-Oxime Enhances Drug Resistance to 5-Fluorouracil Chemotherapy in Colon Cancer Cells.

Liu, Kun-Ping; Luo, Feng; Xie, Si-Ming; Tang, Li-Juan; Chen, Mei-Xiang; Wu, Xue-Fang; Zhong, Xue-Yun; Zhao, Tong

Liu, Kun-Ping; Luo, Feng; Xie, Si-Ming; Tang, Li-Juan; Chen, Mei-Xiang; Wu, Xue-Fang; Zhong, Xue-Yun; Zhao, Tong.

Afiliación

Liu KP; Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China ; Department of Pathology, Qingyuan Hospital, Medical College, Jinan University, Qingyuan 511518, China.

Chin J Cancer Res ; 24(2): 116-23, 2012 Jun.

Article en En | MEDLINE | ID: mdl-23359767

Palabras clave

Colorectal neoplasms; Drug resistance; E2F-1; Fluorouracil; Glycogen synthase kinase 3ß; ß-catenin

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Chin J Cancer Res Año: 2012 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Chin J Cancer Res Año: 2012 Tipo del documento: Article País de afiliación: China